Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2010 by Hallym University Medical Center.
Recruitment status was Not yet recruiting
Information provided by (Responsible Party):
Hallym University Medical Center
First received: September 29, 2010
Last updated: October 4, 2011
Last verified: September 2010
Admission BNP was a useful marker for diagnosing and predicting type IV cardio-renal syndrome type IV in patients with chronic kidney disease admitted to the ICU for acute heart failure in a retrospective study. Therefore, we aim to prospectively investigate the utility of serum BNP in evaluating the treatment adequacy and predicting future cardiac events in patients with type IV CRS.
Chronic Kidney Disease
Acute Heart Failure
||Observational Model: Cohort
Time Perspective: Prospective
||Utility of BNP in Patients With Type IV Cardio-renal Syndrome Admitted to the ICU: a Prospective Observational Study
Biospecimen Retention: Samples Without DNA
Serum sample for BNP level
| Estimated Enrollment:
| Study Start Date:
| Estimated Primary Completion Date:
||August 2012 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Patients with chronic kidney disease admitted to the ICU for acute heart failure (i.e., type IV cardio-renal syndrome)
- Adult patients aged > 18 years, Patients with chronic kidney disease (Serum Cr > 2.0, Documented medical history of chronic kidney disease
- Cardiopulmonary resuscitation, Do-not-resuscitate state, Acute kidney injury, ICU stay < 1 day
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
No Contacts or Locations Provided
No publications provided
||Hallym University Medical Center
History of Changes
|Other Study ID Numbers:
|Study First Received:
||September 29, 2010
||October 4, 2011
||Korea: Food and Drug Administration
Keywords provided by Hallym University Medical Center:
Brain natriuretic peptide
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on October 19, 2014
Renal Insufficiency, Chronic
Natriuretic Peptide, Brain
Physiological Effects of Drugs